Page last updated: 2024-08-23

1-methyl-4-phenylpyridinium and Amyloid Deposits

1-methyl-4-phenylpyridinium has been researched along with Amyloid Deposits in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baek, SH; Jo, DG; Jung, WR; Kim, HG; Kim, KL; Park, DI; Park, JS; Shin, MK	1

Other Studies

1 other study(ies) available for 1-methyl-4-phenylpyridinium and Amyloid Deposits

Article	Year
Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques. Neurobiology of aging, 2014, Volume: 35, Issue:5 Topics: 1-Methyl-4-phenylpyridinium; Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Brain-Derived Neurotrophic Factor; Cell Death; Cells, Cultured; Disease Models, Animal; Glutamic Acid; Humans; Learning; Memory; Mice; Molecular Targeted Therapy; Neurons; Neuroprotective Agents; Oligopeptides; Peptide Fragments; Plaque, Amyloid	2014

Article

Year

Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.

Neurobiology of aging, 2014, Volume: 35, Issue:5

Topics: 1-Methyl-4-phenylpyridinium; Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Brain-Derived Neurotrophic Factor; Cell Death; Cells, Cultured; Disease Models, Animal; Glutamic Acid; Humans; Learning; Memory; Mice; Molecular Targeted Therapy; Neurons; Neuroprotective Agents; Oligopeptides; Peptide Fragments; Plaque, Amyloid

2014